| GOLDMAN SACHS EMERGING MARKETS CORE EQUITY PORTFOLIO P (CLOSE) USD DIS | RVI EMERGENTES | 50,43% | 77,79% | 38,84% | 123,85% |
| GOLDMAN SACHS EMERGING MARKETS EQUITY PORTFOLIO I GBP CAP | RVI EMERGENTES | 50,42% | · | · | · |
| SCHRODER ISF JAPANESE EQUITY I ACC USD (HEDGED) | RVI JAPÓN | 50,42% | 87,12% | 144,85% | 342,08% |
| POLAR CAPITAL ASIAN STARS S EUR CAP | RVI ASIA PACÍFICO | 50,41% | 80,42% | 49,94% | · |
| DWS ESG BIOTECH LC | RVI BIOTECNOLOGÍA | 50,39% | 55,03% | 39,14% | 121,04% |
| MFS MERIDIAN EMERGING MARKETS EQUITY RESEARCH FUND I1-USD | RVI EMERGENTES | 50,37% | 75,41% | · | · |
| ABRDN SICAV I-EMERGING MARKETS SDG EQUITY FUND X ACC USD | RVI EMERGENTES | 50,36% | 71,57% | 40,53% | · |
| CARMIGNAC EMERGENTS A EUR ACC | RVI EMERGENTES | 50,36% | 75,69% | 36,19% | 127,41% |
| MFS MERIDIAN EMERGING MARKETS EQUITY RESEARCH FUND I1-EUR | RVI EMERGENTES | 50,36% | 76,42% | · | · |
| CARMIGNAC PORTFOLIO EMERGENTS FW EUR ACC | RVI EMERGENTES | 50,35% | 77,64% | 41,25% | · |
